日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Imaging-based surrogate classification for risk stratification of hepatocellular carcinoma with microvascular invasion to adjuvant hepatic arterial infusion chemotherapy: a multicenter retrospective study

基于影像学的肝细胞癌微血管侵犯辅助肝动脉灌注化疗风险分层替代分类:一项多中心回顾性研究

Ma, Lidi; Zhang, Cheng; Wen, Yuhua; Xing, Kaili; Li, Shaohua; Geng, Zhijun; Liao, Shuting; Yuan, Shasha; Li, Xinming; Zhong, Chong; Hou, Jing; Zhang, Jie; Gao, Mingyong; Xu, Baojun; Guo, Rongping; Wei, Wei; Xie, Chuanmiao; Lu, Lianghe

Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study

肝动脉灌注化疗后行转化性肝切除术治疗肝细胞癌的疗效比较:一项多中心队列研究

Deng, Min; Zhong, Chong; Li, Dong; Guan, Renguo; Lee, Carol; Chen, Huanwei; Qin, Wei; Cai, Hao; Guo, Rongping; Chen, Zubing

China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)

中国肝癌诊疗指南(2024版)

Zhou, Jian; Sun, Huichuan; Wang, Zheng; Cong, Wenming; Zeng, Mengsu; Zhou, Weiping; Liu, Lianxin; Wen, Tianfu; Kuang, Ming; Zhang, Bixiang; Tao, Kaishan; Han, Guohong; Yan, Zhiping; Wang, Maoqiang; Liu, Ruibao; Guo, Jinhe; Zeng, Zhaochong; Liang, Ping; Ren, Zhenggang; Hou, Jinlin; Zhang, Yanqiao; Liu, Xiufeng; Pan, Hongming; Bi, Feng; Liang, Changhong; Chen, Min; Yan, Fuhua; Xu, Huixiong; Xie, Xiaoyan; Ju, Shenghong; Ji, Yuan; Yun, Jingping; Li, Zengshan; Bai, Xueli; Cai, Dingfang; Chen, Weixia; Chen, Yajin; Chen, Yongjun; Cheng, Wenwu; Cheng, Shuqun; Dai, Zhi; Dai, Chaoliu; Gao, Qiang; Guo, Rongping; Guo, Wengzhi; Guo, Yabing; Hua, Baojin; Huang, Xiaowu; Jiang, Hanyu; Jia, Weidong; Li, Qiu; Li, Tao; Li, Xiangcheng; Li, Xun; Li, Yaming; Li, Yexiong; Liang, Jun; Liang, Xiao; Ling, Changquan; Liu, Hui; Liu, Tianshu; Lu, Shichun; Lv, Guoyue; Mao, Yilei; Meng, Zhiqiang; Peng, Tao; Ren, Weixin; Shi, Guoming; Shi, Hongcheng; Shi, Ming; Song, Tianqiang; Tan, Guang; Wang, Jianhua; Wang, Kui; Wang, Lu; Wang, Wentao; Wang, Xiaoying; Wang, Zhiming; Xiang, Bangde; Xia, Jun; Xing, Baocai; Xu, Jianming; Xu, Jun; Yang, Jianyong; Yang, Xinrong; Yang, Yefa; Yang, Yunke; Yao, Xiaohong; Yin, Zhenyu; Yuan, Zhengang; Zeng, Yongyi; Zeng, Yong; Zhang, Boheng; Zhang, Leida; Zhang, Shuijun; Zhang, Ti; Zhang, Zhiwei; Zhao, Ming; Zhao, Yongfu; Zheng, Honggang; Zhou, Ledu; Zhu, Jiye; Zhu, Kangshun; Shi, Yinghong; Liu, Rong; Zhang, Lan; Xiao, Yongsheng; Yang, Chun; Wu, Zhifeng; Ding, Zhengbin; Zhu, Xiaodong; Tang, Zheng; Huang, Xiaoyong; Han, Hong; Wu, Hong; Chen, Minshan; Wang, Weilin; Li, Qiang; Cai, Jianqiang; Shen, Feng; Cai, Xiujun; Qin, Shukui; Teng, Gaojun; Fan, Jia

Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.

奥沙利铂可诱导肝癌细胞焦亡,并增强机体对肝细胞癌的抗肿瘤免疫力

Deng Min, Zhao Rongce, Zou Hao, Guan Renguo, Wang Jiongliang, Lee Carol, He Benyi, Zhou Jing, Li Shaohua, Wei Wei, Cai Hao, Guo Rongping

Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study

肝动脉介入治疗单独或联合分子靶向治疗和PD-(L)1抑制剂治疗局部侵袭性早期复发性肝细胞癌:一项回顾性研究

Luo, Weixin; Liu, Lixuan; Lin, Wenping; Mei, Jie; Lin, Yansong; Yang, Zhoutian; Liu, Fangyi; Wei, Wei; Guo, Rongping; Yun, Jingping

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Patients with Hepatocellular Carcinoma Receiving HAIC-Based Conversion Hepatectomy: A Dual-Center Retrospective Cohort Study

中性粒细胞/淋巴细胞比值和淋巴细胞/单核细胞比值在接受基于肝动脉灌注化疗的转化性肝切除术的肝细胞癌患者中的预后价值:一项双中心回顾性队列研究

Li, Dong; Fan, Youwen; He, Benyi; Tang, Yajun; Deng, Gang; Guo, Rongping; Deng, Min; Tang, Di

Transarterial chemoembolization versus hepatic arterial infusion chemotherapy as first treatment for hepatocellular carcinoma with macrovascular invasion

经动脉化疗栓塞术与肝动脉灌注化疗作为伴有大血管侵犯的肝细胞癌一线治疗的比较

He, Benyi; Deng, Min; Li, Shaohua; Mei, Jie; Lu, Lianghe; Zuo, Zhijun; Guo, Rongping; Wei, Wei

Reconstitution of pluripotency from mouse fibroblast through Sall4 overexpression

通过Sall4过表达重建小鼠成纤维细胞的多能性

Lizhan Xiao # ,Zifen Huang # ,Zixuan Wu # ,Yongzheng Yang ,Zhen Zhang ,Manish Kumar ,Haokaifeng Wu ,Huiping Mao ,Lihui Lin ,Runxia Lin ,Jingxian Long ,Lihua Zeng ,Jing Guo ,Rongping Luo ,Yi Li ,Ping Zhu ,Baojian Liao ,Luqin Wang ,Jing Liu

Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors

肝细胞癌肝外转移患者可从肝动脉灌注化疗联合乐伐替尼和程序性死亡受体-1抑制剂治疗中获益。

Guan, Renguo; Zhang, Nan; Deng, Min; Lin, Ye; Huang, Guanjie; Fu, Yizhen; Zheng, Zehao; Wei, Wei; Zhong, Chong; Zhao, Haitao; Mei, Jie; Guo, Rongping

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma

比较PD-L1抗体与PD-1抗体联合乐伐替尼和肝动脉灌注化疗治疗不可切除肝细胞癌的疗效

Li, Shaohua; Mei, Jie; Zhao, Rongce; Zhou, Jing; Wang, Qiaoxuan; Lu, Lianghe; Li, Jibin; Zheng, Lie; Wei, Wei; Guo, Rongping